206 related articles for article (PubMed ID: 19211567)
1. Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.
Abdel-Hafiz H; Dudevoir ML; Horwitz KB
J Biol Chem; 2009 Apr; 284(14):9099-108. PubMed ID: 19211567
[TBL] [Abstract][Full Text] [Related]
2. Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
Abdel-Hafiz HA; Horwitz KB
BMC Mol Biol; 2012 Mar; 13():10. PubMed ID: 22439847
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1.
Chauchereau A; Amazit L; Quesne M; Guiochon-Mantel A; Milgrom E
J Biol Chem; 2003 Apr; 278(14):12335-43. PubMed ID: 12529333
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Daniel AR; Faivre EJ; Lange CA
Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
[TBL] [Abstract][Full Text] [Related]
5. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B.
Tung L; Abdel-Hafiz H; Shen T; Harvell DM; Nitao LK; Richer JK; Sartorius CA; Takimoto GS; Horwitz KB
Mol Endocrinol; 2006 Nov; 20(11):2656-70. PubMed ID: 16762974
[TBL] [Abstract][Full Text] [Related]
8. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
9. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
Daniel AR; Lange CA
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14287-92. PubMed ID: 19706513
[TBL] [Abstract][Full Text] [Related]
10. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression.
Abdel-Hafiz H; Takimoto GS; Tung L; Horwitz KB
J Biol Chem; 2002 Sep; 277(37):33950-6. PubMed ID: 12114521
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone.
Jones MC; Fusi L; Higham JH; Abdel-Hafiz H; Horwitz KB; Lam EW; Brosens JJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16272-7. PubMed ID: 17053081
[TBL] [Abstract][Full Text] [Related]
13. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
[TBL] [Abstract][Full Text] [Related]
14. Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.
Wardell SE; Boonyaratanakornkit V; Adelman JS; Aronheim A; Edwards DP
Mol Cell Biol; 2002 Aug; 22(15):5451-66. PubMed ID: 12101239
[TBL] [Abstract][Full Text] [Related]
15. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes.
Molenda-Figueira HA; Murphy SD; Shea KL; Siegal NK; Zhao Y; Chadwick JG; Denner LA; Tetel MJ
Endocrinology; 2008 Oct; 149(10):5272-9. PubMed ID: 18566116
[TBL] [Abstract][Full Text] [Related]
17. Dynamic cell type specificity of SRC-1 coactivator in modulating uterine progesterone receptor function in mice.
Han SJ; Jeong J; Demayo FJ; Xu J; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell Biol; 2005 Sep; 25(18):8150-65. PubMed ID: 16135805
[TBL] [Abstract][Full Text] [Related]
18. Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.
Amazit L; Roseau A; Khan JA; Chauchereau A; Tyagi RK; Loosfelt H; Leclerc P; Lombès M; Guiochon-Mantel A
Mol Endocrinol; 2011 Mar; 25(3):394-408. PubMed ID: 21273440
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.
Narayanan R; Adigun AA; Edwards DP; Weigel NL
Mol Cell Biol; 2005 Jan; 25(1):264-77. PubMed ID: 15601848
[TBL] [Abstract][Full Text] [Related]
20. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1.
Kotaja N; Karvonen U; Jänne OA; Palvimo JJ
J Biol Chem; 2002 Aug; 277(33):30283-8. PubMed ID: 12060666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
